0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Chronic Plaque Psoriasis - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-352
Home | Market Reports | Health | Health Conditions | Skin Conditions
Chronic Plaque Psoriasis Epidemiology Forecast to 2028

Chronic Plaque Psoriasis - Epidemiology Forecast to 2028

Code: DELV-Epid-352
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Chronic Plaque Psoriasis - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Chronic Plaque Psoriasis epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Chronic Plaque Psoriasis Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Chronic Plaque Psoriasis in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Chronic Plaque Psoriasis outlook. It also includes the explanation of changing trends of epidemiology outlining the Chronic Plaque Psoriasis scenario.

Chronic Plaque Psoriasis Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Chronic Plaque Psoriasis thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Chronic Plaque Psoriasis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Chronic Plaque Psoriasis Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Chronic Plaque Psoriasis

Key assessments
• Patient Segmentation in Chronic Plaque Psoriasis
• Chronic Plaque Psoriasis Risk & Burden
• Factors driving growth in a specific Chronic Plaque Psoriasis patient population

1. Report Introduction
2. Chronic Plaque Psoriasis Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Chronic Plaque Psoriasis in 2016
2.2. Patient Share Distribution of Chronic Plaque Psoriasis in 2028
3. Disease Background and Overview: Chronic Plaque Psoriasis
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Chronic Plaque Psoriasis in 7MM
4.3. Total Prevalent/ Incident Patient Population of Chronic Plaque Psoriasis in 7MM – By Countries
5. Epidemiology of Chronic Plaque Psoriasis by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Chronic Plaque Psoriasis
5.1.3. Sub-Type Specific cases of the Chronic Plaque Psoriasis *
5.1.4. Sex- Specific Cases of the Chronic Plaque Psoriasis *
5.1.5. Diagnosed Cases of the Chronic Plaque Psoriasis
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Chronic Plaque Psoriasis
5.4.3. Sub-Type Specific cases of the Chronic Plaque Psoriasis *
5.4.4. Sex- Specific Cases of the Chronic Plaque Psoriasis *
5.4.5. Diagnosed Cases of the Chronic Plaque Psoriasis
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Chronic Plaque Psoriasis
5.5.3. Sub-Type Specific cases of the Chronic Plaque Psoriasis *
5.5.4. Sex- Specific Cases of the Chronic Plaque Psoriasis *
5.5.5. Diagnosed Cases of the Chronic Plaque Psoriasis
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Chronic Plaque Psoriasis
5.6.3. Sub-Type Specific cases of the Chronic Plaque Psoriasis *
5.6.4. Sex- Specific Cases of the Chronic Plaque Psoriasis *
5.6.5. Diagnosed Cases of the Chronic Plaque Psoriasis
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Chronic Plaque Psoriasis
5.7.3. Sub-Type Specific cases of the Chronic Plaque Psoriasis *
5.7.4. Sex- Specific Cases of the Chronic Plaque Psoriasis *
5.7.5. Diagnosed Cases of the Chronic Plaque Psoriasis
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Chronic Plaque Psoriasis
5.8.3. Sub-Type Specific cases of the Chronic Plaque Psoriasis *
5.8.4. Sex- Specific Cases of the Chronic Plaque Psoriasis *
5.8.5. Diagnosed Cases of the Chronic Plaque Psoriasis
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Chronic Plaque Psoriasis
5.9.3. Sub-Type Specific cases of the Chronic Plaque Psoriasis *
5.9.4. Sex- Specific Cases of the Chronic Plaque Psoriasis *
5.9.5. Diagnosed Cases of the Chronic Plaque Psoriasis
6. Unmet Needs of the Chronic Plaque Psoriasis
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Chronic Plaque Psoriasis in 7MM
Table 2: Total Prevalent/Incident Cases of the Chronic Plaque Psoriasis in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Chronic Plaque Psoriasis in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Chronic Plaque Psoriasis in United States (2016-2028)*
Table 6: Diagnosed Cases of the Chronic Plaque Psoriasis in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Chronic Plaque Psoriasis in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Chronic Plaque Psoriasis in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Chronic Plaque Psoriasis in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in France (2016-2028)
Table 12: Sub-Type Specific cases of the Chronic Plaque Psoriasis in France (2016-2028) *
Table 13: Sex- Specific Cases of the Chronic Plaque Psoriasis in France (2016-2028) *
Table 14: Diagnosed Cases of the Chronic Plaque Psoriasis in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Chronic Plaque Psoriasis in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Chronic Plaque Psoriasis in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Chronic Plaque Psoriasis in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Chronic Plaque Psoriasis in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Chronic Plaque Psoriasis in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Chronic Plaque Psoriasis in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Chronic Plaque Psoriasis in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Chronic Plaque Psoriasis in UK (2016-2028) *
Table 26: Diagnosed Cases of the Chronic Plaque Psoriasis in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Chronic Plaque Psoriasis in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Chronic Plaque Psoriasis in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Chronic Plaque Psoriasis in Japan (2016-2028)

Listof figures :

Figure 1: Total Prevalent/Incident Cases of the Chronic Plaque Psoriasis in 7MM
Figure 2: Total Prevalent/Incident Cases of the Chronic Plaque Psoriasis in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Chronic Plaque Psoriasis in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Chronic Plaque Psoriasis in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Chronic Plaque Psoriasis in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Chronic Plaque Psoriasis in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Chronic Plaque Psoriasis in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Chronic Plaque Psoriasis in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Chronic Plaque Psoriasis in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Chronic Plaque Psoriasis in France (2016-2028) *
Figure 14: Diagnosed Cases of the Chronic Plaque Psoriasis in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Chronic Plaque Psoriasis in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Chronic Plaque Psoriasis in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Chronic Plaque Psoriasis in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Chronic Plaque Psoriasis in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Chronic Plaque Psoriasis in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Chronic Plaque Psoriasis in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Chronic Plaque Psoriasis in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Chronic Plaque Psoriasis in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Chronic Plaque Psoriasis in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Chronic Plaque Psoriasis in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Chronic Plaque Psoriasis in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Chronic Plaque Psoriasis in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Chronic Plaque Psoriasis in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global and China Atopic Eczema Treatment Market Size Status and Forecast 2021 2027
Global and China Atopic Eczema Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-35G6515
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global Scar Treatment Product Sales Market Report 2021
Global Scar Treatment Product Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-18X6311
Fri Aug 13 00:00:00 UTC 2021

Add to Cart

Global Dermatology Laser Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Dermatology Laser Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-15X303
Thu Aug 12 00:00:00 UTC 2021

Add to Cart

Global and United States Varicose Vein Treatment Device Market Insights Forecast to 2027
Global and United States Varicose Vein Treatment Device Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-27F3056
Thu Aug 12 00:00:00 UTC 2021

Add to Cart